References
- Gomes T, Mamdani MM, Paterson JM, et al. Trends in high-dose opioid prescribing in Canada. Can Fam Phys. 2014;60(9):826–832.
- Islam MM, McRae IS, Mazumdar S, et al. Prescription opioid analgesics for pain management in Australia: 20 years of dispensing. Intern Med J. 2016;46(8):955–963. doi:https://doi.org/10.1111/imj.12966.
- Van Ryswyk E, Antic NA. Opioids and sleep-disordered breathing. Chest. 2016;150(4):934–944. doi:https://doi.org/10.1016/j.chest.2016.05.022.
- Fleetham J, Ayas N, Bradley D, et al. Canadian Thoracic Society guidelines: diagnosis and treatment of sleep disordered breathing in adults. Can Respir J. 2006; 13:387–392.
- Benjafield A, Valentine K, Ayas N, et al. Global prevalence of obstructive sleep apnea in adults: estimation using currently available data. Am J Respir Crit Care Med. 2018; 197:A3962.
- Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet. 2014;383(9918):736–747. doi:https://doi.org/10.1016/S0140-6736(13)60734-5.
- Tarasiuk A, Greenberg-Dotan S, Brin YS, et al. Determinants affecting health-care utilization in obstructive sleep apnea syndrome patients. Chest. 2005;128(3):1310–1314. doi:https://doi.org/10.1378/chest.128.3.1310.
- Kendzerska T, Gershon AS, Hawker G, et al. Obstructive sleep apnea and risk of cardiovascular events and all-cause mortality: a decade-long historical cohort study. PLoS Med. 2014;11(2):e1001599. doi:https://doi.org/10.1371/journal.pmed.1001599.
- Webster LR, Choi Y, Desai H, et al. Sleep-disordered breathing and chronic opioid therapy. Pain Med. 2008;9(4):425–432. doi:https://doi.org/10.1111/j.1526-4637.2007.00343.x.
- Epstein LJ, Kristo D, Strollo PJ, Jr, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5(3):263–276.
- Zaremba S, Shin CH, Hutter MM, et al. Continuous positive airway pressure mitigates opioid-induced worsening of sleep-disordered breathing early after bariatric surgery. Anesthesiology. 2016;125(1):92–104. doi:https://doi.org/10.1097/ALN.0000000000001160.
- Jaoude P, Lal A, Vermont L, et al. Pain intensity and opioid utilization in response to CPAP therapy in veterans with obstructive sleep apnea on chronic opioid treatment. JCSM.. 2016;12(08):1105–1111. doi:https://doi.org/10.5664/jcsm.6046.
- Mogri M, Nadler J, Khan T, et al. Complex sleep apnea in patients with obstructive sleep apnea on opioids for chronic pain. Sleep Biol Rhythms. 2014;12(2):127–134. doi:https://doi.org/10.1111/sbr.12051.
- Troitino A, Labedi N, Kufel T, et al. Positive airway pressure therapy in patients with opioid-related central sleep apnea. Sleep Breath.. 2014; 18:367–373. doi:https://doi.org/10.1007/s11325-013-0894-4.
- Mason M, Cates CJ, Smith I. Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea. Cochrane Database Syst Rev. 2015;14(7):CD011090.
- Improving health care data in Ontario. ICES investigative report Toronto: Institute for Clinical Evaluative Sciences. 2005.
- Juurlink DN, Institute for Clinical Evaluative Sciences in Ontario. and Canadian Electronic Library (Firm). Canadian Institute for Health Information discharge abstract database a validation study. ICES investigative report. Toronto, Ont.: Institute for Clinical Evaluative Sciences, 2006:1. electronic text (vi, 69 p.).
- Juurlink DP, Croxford R, Chong A, et al. Canadian institute for health information discharge abstract database: a validation study Toronto: Institute for Clinical Evaluative Sciences, 2006. p. 69.
- Assistive Devices Program. Continuous/Autotitrating/BiLevel Positive Pressure Systems. In: Care OMoHaL-T, (ed.). http://www.health.gov.on.ca/en/public/programs/adp/publications/cpap.aspx.
- Tanuseputro P, Budhwani S, Bai YQ, et al. Palliative care delivery across health sectors: a population-level observational study. Palliat Med. 2017;31(3):247–257. doi:https://doi.org/10.1177/0269216316653524.
- Tanuseputro P, Hsu A, Kuluski K, et al. Level of need, divertibility, and outcomes of newly admitted nursing home residents. J Am Med Dir Assoc. 2017;18(7):616–623. doi:https://doi.org/10.1016/j.jamda.2017.02.008.
- Povitz M, Jenkyn KB, Kendzerska T, et al. Clinical pathways and wait times for OSA care in Ontario, Canada: a population cohort study. Can J Respir Crit Care Sleep. 2019;3(2):91–99. doi:https://doi.org/10.1080/24745332.2018.1512841.
- Liu D, Armitstead J, Benjafield A, et al. Trajectories of emergent central sleep apnea during CPAP Therapy. Chest. 2017;152(4):751–760. doi:https://doi.org/10.1016/j.chest.2017.06.010.
- Gomes T, Mastorakos A, Paterson JM, et al. Changes in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis. CMAJ Open. 2017;5(4):E800–E7. doi:https://doi.org/10.9778/cmajo.20170104.
- Busse JW, Craigie S, Juurlink DN, et al. Guideline for opioid therapy and chronic noncancer pain. CMAJ. 2017;189(18):E659–E66. doi:https://doi.org/10.1503/cmaj.170363.
- Pampalon R, Hamel D, Gamache P. A comparison of individual and area-based socio-economic data for monitoring social inequalities in health. Health Rep. 2009; 20:85–94.
- Gomes T, Juurlink DN, Antoniou T, et al. Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study. PLoS Med. 2017;14(10):e1002396. doi:https://doi.org/10.1371/journal.pmed.1002396.
- Kim TW, Samet JH, Cheng DM, et al. The spectrum of unhealthy drug use and quality of care for hypertension and diabetes: a longitudinal cohort study. BMJ Open. 2015;5(12):e008508. doi:https://doi.org/10.1136/bmjopen-2015-008508.
- Gomes T, Juurlink DN, Mamdani MM, et al. Prevalence and characteristics of opioid-related deaths involving alcohol in Ontario, Canada. Drug Alcohol Depend. 2017; 179:416–423. doi:https://doi.org/10.1016/j.drugalcdep.2017.07.008.
- Schultz SE, Rothwell DM, Chen Z, et al. Identifying cases of congestive heart failure from administrative data: a validation study using primary care patient records. Chronic Dis Inj Can. 2013;33(3):160–166.
- Gershon AS, Wang C, Guan J, et al. Identifying individuals with physician diagnosed COPD in health administrative databases. COPD. 2009;6(5):388–394. doi:https://doi.org/10.1080/15412550903140865.
- Gershon AW, Vasilevska-Ristovska J, Guan J, et al. Identifying patients diagnosed with asthma using health administrative data. Can Respir J. 2009;16(6):183–188. doi:https://doi.org/10.1155/2009/963098.
- Jaakkimainen RL, Bronskill SE, Tierney MC, et al. Identification of physician-diagnosed Alzheimer's disease and related dementias in population-based administrative data: a validation study using family physicians' electronic medical records. JAD. 2016;54(1):337–349. doi:https://doi.org/10.3233/JAD-160105.
- Hux JE, Ivis F, Flintoft V, et al. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002;25(3):512–516. doi:https://doi.org/10.2337/diacare.25.3.512.
- Tu K, Campbell NR, Chen ZL, et al. Accuracy of administrative databases in identifying patients with hypertension. Open Med. 2007;1(1):e18–26.
- Austin PC, Daly PA, Tu JV. A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am Heart J. 2002;144(2):290–296. doi:https://doi.org/10.1067/mhj.2002.123839.
- Widdifield J, Bernatsky S, Paterson JM, et al. Accuracy of Canadian health administrative databases in identifying patients with rheumatoid arthritis: a validation study using the medical records of rheumatologists. Arthritis care Res.. 2013; 65:1582–1591. doi:https://doi.org/10.1002/acr.22031.
- Gomes T, Khuu W, Craiovan D, et al. Comparing the contribution of prescribed opioids to opioid-related hospitalizations across Canada: a multi-jurisdictional cross-sectional study. Drug Alcohol Depend. 2018; 191:86–90. doi:https://doi.org/10.1016/j.drugalcdep.2018.06.028.
- Kendzerska T, G T, Gershon AS, et al. Opioid use in adults referred for sleep disorder assessment and associated long‐term consequences. Abstracts of the 24th Congress of the European Sleep Research Society, 25-28 September 2018, Basel, Switzerland. J Sleep Res. 2018; 27 (Suppl 1):e12751.
- Gomes T, Pasricha S, Martins D, et al. Behind the Prescriptions: A Snapshot of Opioid Use across All Ontarians. Toronto: Ontario Drug Policy Research Network 2017.
- Kahan M, Wilson L, Mailis-Gagnon A, National Opioid Use Guideline G, et al. Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations. Can Fam Phys. 2011;57:e419–28.
- Lee-Iannotti J, Parish JM. The epidemic of opioid use: implications for the sleep physician. J Clin Sleep Med. 2014;10(6):645–646. doi:https://doi.org/10.5664/jcsm.3790.
- Povitz M, Kendzerska T, Hanly PJ, et al. Profile of CPAP treated patients in Ontario, Canada, 2006-2013: a population-based cohort study. Sleep Med. 2018; 51:22–28. doi:https://doi.org/10.1016/j.sleep.2018.06.005.
- Brin YS, Reuveni H, Greenberg S, et al. Determinants affecting initiation of continuous positive airway pressure treatment. IMAJ. 2005;7(1):13–18.
- Simon-Tuval T, Reuveni H, Greenberg-Dotan S, et al. Low socioeconomic status is a risk factor for CPAP acceptance among adult OSAS patients requiring treatment. Sleep. 2009;32(4):545–552. doi:https://doi.org/10.1093/sleep/32.4.545.
- Kendzerska T, Gershon AS, Tomlinson G, et al. The effect of patient neighborhood income level on the purchase of continuous positive airway pressure treatment among patients with sleep apnea. Annals ATS. 2016;13(1):93–100. doi:https://doi.org/10.1513/AnnalsATS.201505-294OC.
- Wolkove N, Baltzan M, Kamel H, et al. Long-term compliance with continuous positive airway pressure in patients with obstructive sleep apnea. Can Respir J. 2008;15(7):365–369. doi:https://doi.org/10.1155/2008/534372.
- Lee CHK, Leow LC, Song PR, et al. Acceptance and Adherence to Continuous Positive Airway Pressure Therapy in patients with Obstructive Sleep Apnea (OSA) in a Southeast Asian privately funded healthcare system. Sleep Sci. 2017;10(2):57–63. doi:https://doi.org/10.5935/1984-0063.20170010.
- Yang MC, Lin CY, Lan CC, et al. Factors affecting CPAP acceptance in elderly patients with obstructive sleep apnea in Taiwan. Respir Care. 2013;58(9):1504–1513. doi:https://doi.org/10.4187/respcare.02176.
- Rezaie L, Phillips D, Khazaie H. Barriers to acceptance and adherence to continuous positive airway pressure therapy in patients with obstructive sleep apnea: a report from Kermanshah province, western Iran. PPA.. 2018;Volume 12:1299–1304. doi:https://doi.org/10.2147/PPA.S165905.
- Sawyer AM, Gooneratne NS, Marcus CL, et al. A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev. 2011;15(6):343–356. doi:https://doi.org/10.1016/j.smrv.2011.01.003.